IFITM1 will recognise all 3 isoforms of IFITMs ( IFITM1, IFITM2 and IFITM3).
| Inventor | Institute |
|---|---|
| Elisabeth Trivier | Cancer Research Technology |
| Cat. #: | 151497 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Cancer;Cell signaling and signal transduction;Immunology;Stem cell biology |
| Application: | WB |
| Target: | Interferon-induced transmembrane protein 1 |
| Reactivity: | Human |
| Clone: | IFITM1 |
| Host: | Rabbit |
| Class: | Polyclonal |
| Product description: | Analyses of gene expression of IFN-inducible transmembrane protein (IFITM) levels revealed high levels of expression in early and late intestinal neoplasm in both mice and humans. IFITM gene expression is rapidly induced after activation of the -catenin signalling and expression is significantly up-regulated specifically in colorectal tumors and thus may be a useful diagnostic tool in these tumors. IFITM1 will recognise all 3 isoforms of IFITMs ( IFITM1, IFITM2 and IFITM3). |
|---|---|
| Conjugation: | Unconjugated |
| Immunogen: | HKEEHEVAVLGAPPSTILPRST |
| Target background: | Analyses of gene expression of IFN-inducible transmembrane protein (IFITM) levels revealed high levels of expression in early and late intestinal neoplasm in both mice and humans. IFITM gene expression is rapidly induced after activation of the -catenin signalling and expression is significantly up-regulated specifically in colorectal tumors and thus may be a useful diagnostic tool in these tumors. IFITM1 will recognise all 3 isoforms of IFITMs ( IFITM1, IFITM2 and IFITM3). |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 0.9-1.1 mg/ml |
| Storage conditions: | -15° C to -25° C |
| Shipping conditions: | Dry ice |
| References: |
Singh et al. 2011. J Virol. 85(1):208-16. PMID: 20980524. Association of TRIM22 with the type 1 interferon response and viral control during primary HIV-1 infection. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151030 | Anti-Progesterone [11P14] |
Key Info
Anti-Progesterone [11P14]
|
View Tool | |||||||||||||||||||
| 151015 | Anti-CyclinA [E70.1] |
Key Info
Anti-CyclinA [E70.1]
|
View Tool | |||||||||||||||||||
| 151040 | Anti-CD11 & CD18 [24] |
Key Info
Anti-CD11 & CD18 [24]
|
View Tool | |||||||||||||||||||
| 151017 | Anti-MBP [R29.6] |
Key Info
Anti-MBP [R29.6]
|
View Tool | |||||||||||||||||||
| 151028 | Anti-Cytochrome P450 2C2, 2B1/2 [h7] |
Key Info
Anti-Cytochrome P450 2C2, 2B1/2 [h7]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.